TRHC’s CareKinesis Signs Agreement with Total Life Healthcare - Tabula Rasa HealthCare

TRHC’s CareKinesis Signs Agreement with Total Life Healthcare

Press Releases | Jun 13, 2018

MOORESTOWN, N.J., June 13, 2018 — Tabula Rasa HealthCare (NASDAQ:TRHC) President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA announced TRHC subsidiary CareKinesis has been selected to provide comprehensive medication management services to St. Bernards Total Life Healthcare, a PACE program located in Jonesboro, Arkansas.

PACE, the acronym for Program for All-Inclusive Care of the Elderly, is a Medicare and Medicaid benefit for individuals 55 and older who are nursing home eligible. PACE includes 240 centers in 31 states serving a growing number of eligible Medicare and Medicaid participants. The goal of the program is to keep participants living in their own homes while receiving quality care.

“Following a rigorous selection and interview process, we are pleased to have been chosen as the Medication Risk Mitigation™ and safety provider for Total Life Healthcare,” stated Dr. Knowlton. “The goal of our collaboration is to enhance quality and outcomes, such as reducing ER visits and hospitalization rates. We look forward to starting services officially on July 1, 2018.”

CareKinesis will provide its Medication Risk Mitigation, e-prescribing technology platform, along with pharmacy services. Multi-drug interaction-informed adherence packaging will be used to help avoid preventable adverse drug events, the 4th leading cause of death in the U.S. amongst older adults, according to the Centers for Disease Control.

Total Life Healthcare, in partnership with St. Bernards Medical Center and East Arkansas Area Agency on Aging, is serving eligible seniors in a seven county area, providing managed care with a multi-disciplinary team that includes certified geriatricians. Participants receive preventive care, nutrition services, social services, transportation, prescription drugs, and healthcare-related services.

According to Becky McDaniel, RN, Director of Population Health Management, at Total Life Healthcare, “We look forward to our partnership with CareKinesis. I believe we have selected the best staff and service providers for our clients. They have a stellar reputation for quality pharmacy services and reducing medication risk.”

Joining Ms. McDaniel’s, Total Life Healthcare’s Finance Director, Mr. Terry Combs added, “The CK team is amazing. I don’t think we could have found a better partner.”

PACE is a growing healthcare service in the State of Arkansas. Total Life Healthcare, its first program, started in 2008. A new PACE organization opened in North Little Rock, Arkansas in 2017. A third PACE program is expected to open later this summer in Northwest Arkansas. All three have chosen CareKinesis as their medication safety partner.

PACE organizations nationwide rely on CareKinesis technology, science, and pharmacists who are board-certified in geriatrics, to improve medication outcomes and adherence and to reduce participant hospitalizations.

About Total Life Healthcare
Total Life Healthcare will provide community-based services to enrolled individuals who need medical care and support to continue living at home. It was the first PACE organization in Arkansas and has led the charge in the state. Total Life Healthcare/PACE currently serves nearly 200 seniors in Eastern Arkansas. To learn more about PACE go to St. Bernards Total Life Healthcare.

About CareKinesis/TRHC
CareKinesis partners with healthcare organizations to provide personalized medication therapy management and pharmacy services for high-risk populations. The results are enhanced medication-related outcomes and greater operational efficiency. CareKinesis delivers individually customized medication services using unique robotic technology and a proprietary web-based electronic medication management and reporting platform, EireneRx™. It is the first, national PACE-specific pharmacy and the market leader. For more information, please visit

Forward-Looking Statements

This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

Becky McDaniel
Director of Population Health

Share this:
Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4